Cearvol Wave vs Elehear Beyond

The Cearvol Wave is a budget-priced OTC hearing aid with a visible in-ear style, earning a B grade with a SoundScore of 3.9/5 in our lab testing. At $397, it ranks #22 among 65 OTC hearing aids tested, placing it in the top 32% of its category. This device demonstrates notable strengths in music streaming, scoring 4.1/5—a strong result that sits 2.18 points above the OTC category average. Speech performance is solid in quiet environments at 3.1/5, measuring 0.36 points above average. Speech in noise scores 2.0/5, which is above the category average by 0.56 points, though this remains a mixed result in absolute terms. The Cearvol Wave shows some trade-offs in other areas. Own-voice comfort scores 2.1/5, falling 0.41 points below the category average—a consideration for those sensitive to how their own voice sounds while wearing hearing aids. Feedback handling measures 3.8/5, which is solid in absolute terms, though it sits 0.74 points below the typically strong OTC category average for this metric. The Cearvol Wave is best suited for budget-conscious consumers who prioritize music streaming quality and want solid speech clarity in quieter settings. Those who frequently encounter noisy environments or are particularly sensitive to own-voice quality may want to consider alternatives.

The Elehear Beyond is a behind-the-ear OTC hearing aid priced at $431, earning an A grade with a SoundScore of 4.3/5. This places it in the top 11% of all OTC hearing aids tested, ranking #8 out of 65 devices in its category—a standout result for a budget-tier product. In our lab testing, the Beyond demonstrates particular strength in speech clarity for quiet environments, scoring 4.3/5—a full 1.48 points above the OTC category average. Music streaming quality is another highlight at 3.8/5, measuring 1.88 points above average and delivering solid fidelity for phone audio. Speech understanding in noisy situations scores 2.3/5, which is 0.83 points above the category average but remains mixed in absolute terms—a common limitation among OTC devices. Feedback handling is excellent at 4.5/5, providing stable performance during typical use. Own-voice comfort scores 2.6/5, slightly above the category average but still in mixed territory, which may be noticeable for some users during conversation. The Beyond earned a 2024 Expert's Choice Award and represents strong value in the budget OTC segment. It outperforms several same-price competitors including the Apple AirPods Pro 2 and Zepp Clarity Omni. This device is best suited for those seeking reliable speech clarity in quieter settings and quality streaming audio without the higher cost of prescription alternatives.